retatrutide safety trial Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Phase 1 Trials |
Description
For those who qualify, TrimRX provides customized weight loss plans that incorporate GLP-1 medications such as semaglutide or tirzepatide

The pitch is compelling, especially if you've been quoted 150+ per month for a prescription weight loss injection

Co-pay and deductibles related to insurance apply

In practice, microdoses are usually a fraction of the standard starting dose (for example, 0.125 mg or 0.25 mg of semaglutide rather than 0.5 mg)

Use our free pharmacokinetic calculator to see when each dose reaches steady state so you can plan around the highest-risk weeks

Could you check if our company's Kaiser plan includes weight loss drug coverage
